Cleared Special

K201590 - EMMA Capnograph

K201590 is the FDA 510(k) clearance for EMMA Capnograph by Masimo Corporation. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Special 510(k) pathway after a 290-day FDA review.

K201590 · Masimo Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
290d
Days
Class 2
Risk

K201590 is an FDA 510(k) clearance for the EMMA Capnograph. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on March 29, 2021 after a review of 290 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Masimo Corporation devices

Submission Details

510(k) Number K201590 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2020
Decision Date March 29, 2021
Days to Decision 290 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 140d · This submission: 290d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 123
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K201590.
CARESCAPE CO2 Microstream parameter
K213518 · Covidien, LLC · Apr 2022
CARESCAPE Respiratory Modules E-sCO, E-sCOV, E-sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOVX, E-sCAiOE, E-sCAiOVE and accessories
K211171 · GE Healthcare Finland Oy · Oct 2021
Nellcor EASYCAP II Adult Colorimetric CO2 Detector, Nellcor PEDCICAP Pediatric Colorimetric CO2 Detector
K203762 · Covidien · Sep 2021
Unimed CO2 Mainstream Module Model Capno-M, Unimed CO2 Mainstream Module Model Capno-M+
K210019 · Unimed Medical Supplies, Inc. · Mar 2021
CO2 Sidestream Module
K192488 · Beijing Kingst Commercial & Trade Co., Ltd. · May 2020
CO2 Mainstream Module
K192446 · Beijing Kingst Commercial & Trade Co., Ltd. · May 2020